Our findings are consistent with prior reports indicating that VEGF expression, while reflective of angiogenic activity, is not a reliable standalone prognostic biomarker in early-stage cervical cancer treated surgically [25]. This evidence concerns the gene VEGFA and cervical carcinoma.